Breast and Ovarian Cancer [NEW TOPIC PAGE]

Main|Search|PHGKB




Last Posted: Feb 21, 2019

---

• Consensus guidelines for genetic testing for hereditary breast and ovarian cancer
  American Society for Breast Surgeons, February 14, 2019
• Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers.
  Stewart Martha E et al. Gynecologic oncology reports 2019 May 2818-22
• The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway.
  Asphaug Lars et al. MDM policy & practice 4(1) 2381468318821103
• [Hereditary predisposition to breast cancer (1): genetics].
  Cohen-Haguenauer Odile et al. Medecine sciences : M/S 2019 Feb 35(2) 138-151
• A common SNP in the uracil-DNA glycosylase gene UNG decreases ovarian cancer risk in BRCA2 mutation carriers.
  Baquero Juan Miguel et al. Molecular oncology 2019 Feb
• Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies.
  Toss Angela et al. Cancers 2019 Feb 11(2)
• High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
  Bick Ulrich et al. Breast cancer research and treatment 2019 Feb
• Painting a portrait: Analysis of national health survey data for cancer genetic counseling.
  Stamp Monica H et al. Cancer medicine 2019 Feb
• Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
  So Min-Kyung et al. Breast cancer (Tokyo, Japan) 2019 Feb
• Are young women ready for BRCA testing? Comparing attitudes and comprehension of two age groups of healthy Italian women.
  Gavaruzzi Teresa et al. Patient education and counseling 2019 Jan

more